SYS-CON MEDIA Authors: Doug Masi, Mat Mathews, Newswire, David Smith, Tim Crawford

News Feed Item

Walking Raven Announces Doors Open For Retail Marijuana Sales On Saturday, January 18, 2014 At 9am

DENVER, Jan. 17, 2014 /PRNewswire/ -- Walking Raven, Denver's first official medical marijuana dispensary applicant in August 2009, received their retail marijuana business license on Thursday, January 16, 2014.

Walking Raven, located on S Broadway and Asbury, in the now famous "Green Mile" or "Broadsterdam" section of Denver, will be joining the historic handful of stores that have completed the state and city licensing process; opening their doors to adult retail marijuana sales on Saturday, January 18, 2014.

For almost five years, Walking Raven has effectively used their business as a platform to change their community's perception of cannabis consumers and generate new revenues for the local economy. The Co-Owner and Executive Manager, Luke Ramirez, explains "We are very excited to be a part of Colorado's historic transition to legal cannabis sales; we look forward to helping Denver's current shortage of legal cannabis by providing premium grade products. We are also eager to hire additional staff and provide more resources to the Denver community through retail cannabis taxes and our charity efforts."

Walking Raven is known for being a shop that carries premium grade cannabis grown by expert cultivators. Their most popular strain, "Hong Kong Diesel", exclusive to Walking Raven, is well known among Colorado medical patients and will now be available to anyone over the age of 21 on Saturday, January 18, 2014 at 9:00 am.

For more information on this topic, or to schedule an interview regarding Walking Raven please contact Luke Ramirez at (303) 513-8775 or email Luke at [email protected]

Luke Ramirez, Co-Owner, Executive Manager
(303) 513-8775, [email protected]

SOURCE Walking Raven

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.